Noile-Immune Biotech (TSE:4893) YoY EBITDA Growth : -27.51% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Noile-Immune Biotech's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -27.51%.

Noile-Immune Biotech's EBITDA per Share for the three months ended in Mar. 2024 was 円-7.84.

Noile-Immune Biotech YoY EBITDA Growth Historical Data

The historical data trend for Noile-Immune Biotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech YoY EBITDA Growth Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-38.34

85.45

-588.73

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial				-	-	-	38.41	-27.51

Noile-Immune Biotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Noile-Immune Biotech's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-18.699	-	-2.715)	/	\| -2.715 \|
=	-588.73 %

Noile-Immune Biotech's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-7.838	-	-6.147)	/	\| -6.147 \|
=	-27.51 %

Noile-Immune Biotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines